IL37 and hyperuricemia: Hyperuricemia and the persistent activation of the interleukin 23 and 17 (IL-23/IL-17) axis can result in a condition that combines the features of psoriatic disease and gout and introduces a new phenotype of the disease that is more inflammatory and destructive in nature.